In this edition: Drug prices, Tylenol and DIY healthcare

The White House, Pfizer and drug prices. President Trump unveiled plans to launch a government-run website, dubbed TrumpRx, for consumers to buy drugs directly from manufacturers. Pfizer pledged to offer some of its drugs on the site at a reduced rate and make a big investment in the U.S.

Why Pfizer's deal is good for Big Pharma. The big picture is that Trump’s pressure campaign on the pharmaceutical industry might be winding down. Since most companies are pledging large investments in U.S. manufacturing, they should now be able to steer clear of heavy tariffs.

Why newborns get the hepatitis B shot. It’s the first vaccine most U.S. babies receive, which doctors say is responsible for virtually eliminating childhood cases. Now the Trump administration is considering delaying the shot. Doctors warn that even a delay of a few months would lead to more childhood cases and ultimately deaths.

Diagnosing yourself without a doctor. Patients are increasingly turning to do-it-yourself healthcare amid long waits for medical appointments and a rise in self-care options.

Blood clot diagnosis. Readers told a WSJ editor all sorts of stories about why doctors wrote off or misjudged their symptoms. They gave some advice on the road to recovery and how to take care of yourself after such a medical scare.

Inside the Tylenol crisis. The chief executive behind the over-the-counter medication thought he’d found a way to work with the Trump administration. Then everything went off the rails.

Luring U.S. drugmakers back from Ireland won't be easy. The town of Ringaskiddy has been transformed over the years from rural backwater to U.S. global pharma manufacturing hub as drugmakers invested in manufacturing there. Now President Trump wants companies to bring their manufacturing back home.

This newsletter was compiled by the WSJ’s Health & Science team. Follow us on X @WSJHealth and @WSJScience. Email us by replying to this newsletter. Got a tip for us? Here's how to submit.